Patient Centric Sampling Resources
Explore our patient centric sampling resources to get an insight into how this approach is being successfully deployed for a number of fields and applications. This content is selected from the PCSIG website and from the websites of other organisations.
PCSIG takes no responsibilities for the accuracy of the content provided from external websites.
If you have any suggestions of content that you think would be useful to add to this page, then please write to contact@pcsig.org
Physician Led Healthcare
Economic Use Cases
Sport
Logistics
Patient Perspectives
External Article
DIY Blood Sampling for Pediatric Clinical Trials—The Patients Perspective (Sep 2019)
Enaksha Wickremsinhe (Eli Lilly and Company); Mary Short (Eli Lilly and Company); Brandon Talkington (Eli Lilly and Company); Leanne West (Georgia Institute of Technology and International Children’s Advisory Network.
Patient Populations
Pharmaceutical Development
External Article
Will patient-centric sampling become the norm for clinical trials after COVID-19? (Nov 2020)
Christopher A. James (Amgen Research); Matthew D. Barfield (Roche); Katie F. Maass (Genentech); Shefali R. Patel (Janssen R&D); Melanie D. Anderson (Merck)
External Article
DIY Blood Sampling for Pediatric Clinical Trials—The Patients Perspective (Sep 2019)
Enaksha Wickremsinhe (Eli Lilly and Company); Mary Short, (Eli Lilly and Company); Brandon Talkington (Eli Lilly and Company);. Leanne West (Georgia Institute of Technology and International Children’s Advisory Network)
Public Health
PCSIG Webinar
Advancing the collection and analysis of PFAS in blood (March 2024)
Andrew Patterson (Eurofins Environment, North America)
Consumer Led Healthcare
Analytical Considerations
PCSIG Webinar
Advancing the collection and analysis of PFAS in blood (March 2024)
Andrew Patterson (Eurofins Environment, North America)
PCSIG Webinar
External Article
Regulation & Governance
Sampling Technologies
External Article
